Pacer Advisors’s Vera Therapeutics VERA Stock Holding History

Pacer Advisors’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-693	Closed	-$25.1K	–	2704
2024 Q2	$25.1K	Sell	693 -117	-14%	-$4.64K	﹤0.01%	3385
2024 Q1	$34.9K	Buy	+810	New	+$28.9K	﹤0.01%	3310

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors's VERA Position: Q3 2024 in Review

Pacer Advisors sold out of Vera Therapeutics (VERA) in Q3 2024, closing a stake of 693 shares — an estimated $25.1K sold.

Pacer Advisors first reported a position in VERA in Q1 2024 and held it in 2 quarters. The position peaked at $34.9K in Q1 2024. 173 funds tracked by Wall St. Rank hold VERA as of Q3 2024.

Pacer Advisors reported no remaining Vera Therapeutics position as of Q3 2024 after selling out during the quarter.
Pacer Advisors sold 693 Vera Therapeutics shares in Q3 2024, an estimated $25.1K.
Pacer Advisors first reported a position in Vera Therapeutics in Q1 2024 and held it in 2 quarters.
Pacer Advisors's Vera Therapeutics position peaked at $34.9K in Q1 2024.
173 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.